Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date28 Feb 2020 |
100 Clinical Results associated with Sinopharm Group Jingfang (Anhui) Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Sinopharm Group Jingfang (Anhui) Pharmaceutical Co., Ltd.
100 Deals associated with Sinopharm Group Jingfang (Anhui) Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Sinopharm Group Jingfang (Anhui) Pharmaceutical Co., Ltd.